NCT04211558View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics of Single Oral Doses of Ozanimod in Healthy Adult Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

September 26, 2020

Study Completion Date

October 9, 2020

Conditions
Healthy Volunteer
Interventions
DRUG

Ozanimod

Ozanimod

Trial Locations (1)

100029

Capital Medical University - Beijing Anzhen Hospital, Beijing

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY

NCT04211558 - A Study to Evaluate the Pharmacokinetics of Single Oral Doses of Ozanimod in Healthy Adult Chinese Subjects | Biotech Hunter | Biotech Hunter